Skip to main navigation Skip to search Skip to main content

Insulin glargine (Lantus) and cancer risk

  • Mark Abramowicz
  • , Gianna Zuccotti
  • , Jean Marie Pflomm
  • , Susan M. Daron
  • , Blaine M. Houst
  • , Corinne E. Zanone
  • , Jules Hirsch
  • , Gerald L. Mandell
  • , Dan M. Roden
  • , Carl W. Bazil
  • , Vanessa K. Dalton
  • , Eric J. Epstein
  • , David N. Juurlink
  • , Richard B. Kim
  • , Hans Meinertz
  • , Sandip K. Mukherjee
  • , F. Estelle R. Simons
  • , Jordan W. Smoller
  • , Neal H. Steigbigel
  • , Donna Goodstein
  • Amy Faucard, Cynthia Macapagal Covey, Vincent Teo, Susie Wong, Liz Donohue, Cheryl Brown, Gene Carbona, Cristine Romatowski, Joanne F. Valentino, Yosef Wissner-Levy

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish (US)
Pages (from-to)67-68
Number of pages2
JournalMedical Letter on Drugs and Therapeutics
Volume51
Issue number1319
StatePublished - Aug 24 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this